News and Press Releases Search About the CF Foundation Research Drug Pipeline Public Policy Our Research Approach Advocacy Antibiotics Coronavirus (COVID-19) Patient Registry Care Centers Care Team CFTR Modulators Clinical Trials Cystic Fibrosis Foundation Therapeutics (CFFT) Fitness Germs Get Involved Health Care Reform Medications North American CF Conference Patient Assistance (-) Infections (-) 2021 2007 (-) News Infections CF Foundation Invests $3.5 Million in Pulmocide for Development of Novel Antifungal Treatment for Lung Transplant Recipients The treatment has the potential to prevent Aspergillus fungal infections in people who have had a lung transplant. Dec. 6, 2021 | 4 min read